Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy.
about
Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.Mechanisms of disease: hypertrophic cardiomyopathy.Patterns of left ventricular remodeling in aortic stenosis: therapeutic implications.Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM).A multidimensional sight on cardiac failure: uncovered from structural to molecular level.Left ventricular outflow tract gradient is associated with reduced capillary density in hypertrophic cardiomyopathy irrespective of genotype.Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal.The role of coronary microvascular disorder in congestive heart failure.Does relief of outflow tract obstruction in patients with hypertrophic cardiomyopathy improve long-term survival? Implications for lowering the threshold for surgical myectomy and alcohol septal ablation.Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography.T1 mapping in children and young adults with hypertrophic cardiomyopathy.Mechanical dyssynchrony and diastolic dysfunction are common in LVH: a pilot correlation study using Doppler echocardiography and CZT gated-SPECT MPI.Follow-up and prognosis of HCM
P2860
Q35072520-0280D276-183F-4172-A0AF-215936496E50Q37949516-AAAE80F0-BDC9-4E7C-9681-A7A488DB896EQ38492359-DCBD2C86-96C2-4C89-A857-B83705AD6429Q38723494-BA13361F-6592-4F06-835D-DA151DF6D453Q39285223-B7534C4F-BB02-48CA-BD72-5748CA37FEEAQ40458508-6AE53823-D356-46BB-920E-D4F35F8698C0Q40492999-BF136CEF-156C-4C5F-BAB3-FED681861436Q41159804-608EE865-CA61-4E16-927B-0FA64C69EB47Q42330841-5C3AE201-B19D-41DD-B1F6-EC63CFC12A8DQ47103526-C9781194-0CAB-46DA-8D7E-5085BED57935Q51155770-8748D8A6-F137-43FA-98A1-2FBF1C3445B5Q52665749-893AF4A6-88DE-4BC1-8013-BF354895498BQ58565523-7B248240-102E-4ED9-A00A-A7D3F9EF2289
P2860
Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Microvascular dysfunction, myo ...... h hypertrophic cardiomyopathy.
@en
Microvascular dysfunction, myo ...... h hypertrophic cardiomyopathy.
@nl
type
label
Microvascular dysfunction, myo ...... h hypertrophic cardiomyopathy.
@en
Microvascular dysfunction, myo ...... h hypertrophic cardiomyopathy.
@nl
prefLabel
Microvascular dysfunction, myo ...... h hypertrophic cardiomyopathy.
@en
Microvascular dysfunction, myo ...... h hypertrophic cardiomyopathy.
@nl
P2093
P2860
P1476
Microvascular dysfunction, myo ...... h hypertrophic cardiomyopathy.
@en
P2093
Aurelio Sgalambro
Barbara Sotgia
Davide Antoniucci
Iacopo Olivotto
Massimo Baldi
Paolo G Camici
Roberto Sciagrà
P2860
P2888
P304
P356
10.1007/S12265-009-9142-5
P407
P577
2009-11-03T00:00:00Z